Ophthalmology Outcomes
Retina Surgery
Our Retina Service is one of the largest subspecialty groups of its kind in the country. Our clinicians are highly skilled at diagnosing and treating the full range of retinal conditions, including macular degeneration, diabetic retinopathy, retinal detachments, ocular tumors, intraocular infections, and severe ocular injuries.
Learn more about retina careOf the 401 included procedures for retinal detachments:
- 1 was a pneumatic retinopexy (100% had an attached retina after one surgery)
- 33 were scleral buckle procedures [90.9% (n=30) had an attached retina after one surgery, and 100% had an attached retina after multiple surgeries]
- 70 were combined scleral buckle and pars plana vitrectomy [98.6% (n=69) had an attached retina after one surgery, and 100% had an attached retina after multiple surgeries]
- 297 were pars plana vitrectomies [94.6% (n=281) had an attached retina after one surgery, and 100% had an attached retina after multiple surgeries)
With a 100% reattachment rate for primary RRD repair after one or more surgeries, the Mass Eye and Ear Retina Service continues to maintain high success rates for this procedure. For the past 12 years, the Retina Service has consistently met international benchmarks of 97% to 100% for successful RRD repair.1-5
Although rare, acute endophthalmitis is a potential complication of intravitreal injections. At Mass Eye and Ear, rates of endophthalmitis after intravitreal injection are low compared to international benchmarks.5
The endophthalmitis rate for calendar year 2023 is similar to the overall rate for the past 14 calendar years, where the overall rate of endophthalmitis after intravitreal injection was 0.016% (30 of 179,324 injections).
Proton beam irradiation was developed at Mass Eye and Ear in conjunction with a team of radiotherapists from Massachusetts General Hospital. In 1975, the first proton beam irradiation treatment was administered to a Mass Eye and Ear patient with intraocular malignant melanoma1.
Read More
Single Surgery Reattachment Rate for Primary Rhegmatogenous Retinal Detachment
1. Soni C, Hainsworth DP, Almony A. Surgical management of rhegmatogenous retinal detachment: a meta-analysis of randomized controlled trials. Ophthalmology 2013; 120(7): 1440-1447.
2. Feltgen N, Heimann H, Hoerauf H, et al. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR study): Risk assessment of anatomical outcome. SPR study report no.7. Acta Ophthalmol 2013: 91(3): 282-287.3. Adelman RA, Parnes AJ, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Strategy for the management of uncomplicated retinal detachments: the European Vitreo-Retinal Society retinal detachment study report 1. Ophthalmology 2013; 120(9): 1804-1808.
4. Sodhi A, Leung LS, Do DV, et al. Recent trends in the management of rhegmatogenous retinal detachment. Surv Ophthalmol 2008; 53(1): 50-67.
5. Day S, Grossman DS, Mruthyunjaya P, et al. One-year outcomes after retinal detachment surgery among medicare beneficiaries. Am J Ophthalmol 2010; 150(3): 338 345.
Final Retinal Reattachment Rate for Primary Rhegmatogenous Retinal Detachment
1. Han DP, Mohsin NC, Guse CE, et al. Comparison of pneumatic retinopexy and scleral buckling in the management of primary rhegmatogenous retinal detachment. Southern Wisconsin Pneumatic Retinopexy Study Group. Am J Ophthalmol 1998; 126(5): 658-668.
2. Avitabile T, Bartolotta G, Torrisi B, et al. A randomized prospective study of rhegmatogenous retinal detachment cases treated with cryopexy versus frequency-doubled Nd:YAG laser-retinopexy during episcleral surgery. Retina 2004; 24(6), 878-882.
3. Azad RV, Chanana B, Sharma YR, et al. Primary vitrectomy versus conventional retinal detachment surgery in phakic rhegmatogenous retinal detachment. Acta Ophthalmol Scand 2007; 85(5): 540-545.
4. Sullivan PM, Luff AJ, Aylward GW. Results of primary retinal reattachment surgery: a prospective audit. Eye 1997; 11(Pt6): 869-871.
5. Day S, Grossman DS, Mruthyunjaya P, et al. One-year outcomes after retinal detachment surgery among medicare beneficiaries. Am J Ophthalmol 2010; 150(3): 338-345.
Macular Hole Surgery: Single Surgery Success Rate at Three Months
1. Wu D, Ho LY, Lai M, et al. Surgical outcomes of idiopathic macular hole repair with limited postoperative positioning. Retina 2011; 31 (3): 609-611.
2. Smiddy WE, Feuer W, Cordahi G. Internal limiting membrane peeling in macular hole surgery. Ophthalmology 2001; 108(8): 1471-1478.
3. Guillaubey A, Malvitte L, Lafontaine PO, et al. Comparison of face-down and seated position after idiopathic macular hole surgery: a randomized clinical trial. Am J Ophthalmol 2008; 146(1): 128-134.
Rates of Endophthalmitis After Intravitreal Injection
1. Bhavsar AR, Googe JM Jr, Stockdale CR, et al. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol 2009; 127(12): 1581-1583.
2. Englander M, Chen TC, Paschalis EI, et al. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol 2013; 97(4): 460-465.
3. Fileta JB, Scott IU, Flynn HW Jr. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina 2014; 45(2): 143-149.
4. VanderBeek BL, Bonaffini SG, Ma L. Association of compounded bevacizumab with postinjection endophthalmitis. JAMA Ophthalmol 2015; 133(10): 1159 1164.
5. Dossarps D, Bron AM, Koehrer P, et al. Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol 2015; 160(1): 17-25.
Management of Intraocular Tumors: Tumor Recurrence After Proton Therapy
1. Gragoudas ES, Egan KM, Seddon JM, et al. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992, 99: 760-766.
